Loading…
Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas
The blood-brain barrier (BBB) plays important roles in brain tumor pathogenesis and treatment response, yet our understanding of its function and heterogeneity within or across brain tumor types remains poorly characterized. Here we analyze the neurovascular unit (NVU) of pediatric high-grade glioma...
Saved in:
Published in: | Acta neuropathologica communications 2021-08, Vol.9 (1), p.142-142, Article 142 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c594t-75d275278f65521d255f9f865a9e522353b4079ca53b5f4f17d6b8ef081ea5c43 |
---|---|
cites | cdi_FETCH-LOGICAL-c594t-75d275278f65521d255f9f865a9e522353b4079ca53b5f4f17d6b8ef081ea5c43 |
container_end_page | 142 |
container_issue | 1 |
container_start_page | 142 |
container_title | Acta neuropathologica communications |
container_volume | 9 |
creator | Wei, Xin Meel, Michaël H Breur, Marjolein Bugiani, Marianna Hulleman, Esther Phoenix, Timothy N |
description | The blood-brain barrier (BBB) plays important roles in brain tumor pathogenesis and treatment response, yet our understanding of its function and heterogeneity within or across brain tumor types remains poorly characterized. Here we analyze the neurovascular unit (NVU) of pediatric high-grade glioma (pHGG) and diffuse midline glioma (DMG) using patient derived xenografts and natively forming glioma mouse models. We show tumor-associated vascular differences between these glioma subtypes, and parallels between PDX and mouse model systems, with DMG models maintaining a more normal vascular architecture, BBB function and endothelial transcriptional program relative to pHGG models. Unlike prior work in angiogenic brain tumors, we find that expression of secreted Wnt antagonists do not alter the tumor-associated vascular phenotype in DMG tumor models. Together, these findings highlight vascular heterogeneity between pHGG and DMG and differences in their response to alterations in developmental BBB signals that may participate in driving these pathological differences. |
doi_str_mv | 10.1186/s40478-021-01243-1 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_577c7abe343a43c39671695146a4f1f4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A673028865</galeid><doaj_id>oai_doaj_org_article_577c7abe343a43c39671695146a4f1f4</doaj_id><sourcerecordid>A673028865</sourcerecordid><originalsourceid>FETCH-LOGICAL-c594t-75d275278f65521d255f9f865a9e522353b4079ca53b5f4f17d6b8ef081ea5c43</originalsourceid><addsrcrecordid>eNptkk1rHSEUhofS0oQ0f6CLMlAo3Uzq5-hsCiH9CgS6adfi1eOMlxlN1Qnk39ebm6b3lurCgz7vKx7fpnmN0QXGsv-QGWJCdojgDmHCaIefNacEcdzxoUfPD-qT5jznLapjwJhK-bI5oYwRPiBx2thP4HzwYWzLusTU6Zyj8bqAbe90NuusUztBgRRHCODLfetDewu2IsmbdvLj1I1JW2h1sK31zq0Z2sXb2Qdox9nHRedXzQun5wznj-tZ8_PL5x9X37qb71-vry5vOsMHVjrBLRGcCOl6zgm2hHM3ONlzPQAnhHK6YUgMRteCO-awsP1GgkMSg-aG0bPmeu9ro96q2-QXne5V1F49bMQ0Kp2KNzMoLoQRegOUUc2ooUMvcD9wzHpdjd3O6-Pe63bdLGANhJL0fGR6fBL8pMZ4pySVmHNRDd4_GqT4a4Vc1OKzgXnWAeKaFeE9w5Rhwiv69h90G9cUaqsqJRiTgxTiLzXq-gAfXKz3mp2puuwFRUTWVlXq4j9UnRYWb2Ko3133jwTvDgQT6LlMOc5r8THkY5DsQZNizgncUzMwUrtMqn0mVc2kesikwlX05rCNT5I_CaS_AS9_2hE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2574489877</pqid></control><display><type>article</type><title>Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Wei, Xin ; Meel, Michaël H ; Breur, Marjolein ; Bugiani, Marianna ; Hulleman, Esther ; Phoenix, Timothy N</creator><creatorcontrib>Wei, Xin ; Meel, Michaël H ; Breur, Marjolein ; Bugiani, Marianna ; Hulleman, Esther ; Phoenix, Timothy N</creatorcontrib><description>The blood-brain barrier (BBB) plays important roles in brain tumor pathogenesis and treatment response, yet our understanding of its function and heterogeneity within or across brain tumor types remains poorly characterized. Here we analyze the neurovascular unit (NVU) of pediatric high-grade glioma (pHGG) and diffuse midline glioma (DMG) using patient derived xenografts and natively forming glioma mouse models. We show tumor-associated vascular differences between these glioma subtypes, and parallels between PDX and mouse model systems, with DMG models maintaining a more normal vascular architecture, BBB function and endothelial transcriptional program relative to pHGG models. Unlike prior work in angiogenic brain tumors, we find that expression of secreted Wnt antagonists do not alter the tumor-associated vascular phenotype in DMG tumor models. Together, these findings highlight vascular heterogeneity between pHGG and DMG and differences in their response to alterations in developmental BBB signals that may participate in driving these pathological differences.</description><identifier>ISSN: 2051-5960</identifier><identifier>EISSN: 2051-5960</identifier><identifier>DOI: 10.1186/s40478-021-01243-1</identifier><identifier>PMID: 34425907</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Animals ; Antibodies ; Blood brain barrier ; Blood-Brain Barrier - pathology ; Brain - blood supply ; Brain - pathology ; Brain cancer ; Brain Neoplasms - pathology ; Brain tumors ; Child ; Diffuse intrinsic pontine glioma ; Diffuse midline glioma ; Endothelial cells ; Glioma ; Glioma - pathology ; Gliomas ; Histology ; Humans ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Mutation ; Neoplasm Grading - methods ; Neurovascular Coupling - physiology ; Neurovascular unit ; Pediatric high-grade glioma ; Pediatrics ; Plasmids ; Tumors ; Xenograft Model Antitumor Assays - methods</subject><ispartof>Acta neuropathologica communications, 2021-08, Vol.9 (1), p.142-142, Article 142</ispartof><rights>2021. The Author(s).</rights><rights>COPYRIGHT 2021 BioMed Central Ltd.</rights><rights>2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c594t-75d275278f65521d255f9f865a9e522353b4079ca53b5f4f17d6b8ef081ea5c43</citedby><cites>FETCH-LOGICAL-c594t-75d275278f65521d255f9f865a9e522353b4079ca53b5f4f17d6b8ef081ea5c43</cites><orcidid>0000-0003-4771-4003</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381557/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2574489877?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34425907$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wei, Xin</creatorcontrib><creatorcontrib>Meel, Michaël H</creatorcontrib><creatorcontrib>Breur, Marjolein</creatorcontrib><creatorcontrib>Bugiani, Marianna</creatorcontrib><creatorcontrib>Hulleman, Esther</creatorcontrib><creatorcontrib>Phoenix, Timothy N</creatorcontrib><title>Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas</title><title>Acta neuropathologica communications</title><addtitle>Acta Neuropathol Commun</addtitle><description>The blood-brain barrier (BBB) plays important roles in brain tumor pathogenesis and treatment response, yet our understanding of its function and heterogeneity within or across brain tumor types remains poorly characterized. Here we analyze the neurovascular unit (NVU) of pediatric high-grade glioma (pHGG) and diffuse midline glioma (DMG) using patient derived xenografts and natively forming glioma mouse models. We show tumor-associated vascular differences between these glioma subtypes, and parallels between PDX and mouse model systems, with DMG models maintaining a more normal vascular architecture, BBB function and endothelial transcriptional program relative to pHGG models. Unlike prior work in angiogenic brain tumors, we find that expression of secreted Wnt antagonists do not alter the tumor-associated vascular phenotype in DMG tumor models. Together, these findings highlight vascular heterogeneity between pHGG and DMG and differences in their response to alterations in developmental BBB signals that may participate in driving these pathological differences.</description><subject>Animals</subject><subject>Antibodies</subject><subject>Blood brain barrier</subject><subject>Blood-Brain Barrier - pathology</subject><subject>Brain - blood supply</subject><subject>Brain - pathology</subject><subject>Brain cancer</subject><subject>Brain Neoplasms - pathology</subject><subject>Brain tumors</subject><subject>Child</subject><subject>Diffuse intrinsic pontine glioma</subject><subject>Diffuse midline glioma</subject><subject>Endothelial cells</subject><subject>Glioma</subject><subject>Glioma - pathology</subject><subject>Gliomas</subject><subject>Histology</subject><subject>Humans</subject><subject>Mice</subject><subject>Mice, Inbred NOD</subject><subject>Mice, SCID</subject><subject>Mutation</subject><subject>Neoplasm Grading - methods</subject><subject>Neurovascular Coupling - physiology</subject><subject>Neurovascular unit</subject><subject>Pediatric high-grade glioma</subject><subject>Pediatrics</subject><subject>Plasmids</subject><subject>Tumors</subject><subject>Xenograft Model Antitumor Assays - methods</subject><issn>2051-5960</issn><issn>2051-5960</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk1rHSEUhofS0oQ0f6CLMlAo3Uzq5-hsCiH9CgS6adfi1eOMlxlN1Qnk39ebm6b3lurCgz7vKx7fpnmN0QXGsv-QGWJCdojgDmHCaIefNacEcdzxoUfPD-qT5jznLapjwJhK-bI5oYwRPiBx2thP4HzwYWzLusTU6Zyj8bqAbe90NuusUztBgRRHCODLfetDewu2IsmbdvLj1I1JW2h1sK31zq0Z2sXb2Qdox9nHRedXzQun5wznj-tZ8_PL5x9X37qb71-vry5vOsMHVjrBLRGcCOl6zgm2hHM3ONlzPQAnhHK6YUgMRteCO-awsP1GgkMSg-aG0bPmeu9ro96q2-QXne5V1F49bMQ0Kp2KNzMoLoQRegOUUc2ooUMvcD9wzHpdjd3O6-Pe63bdLGANhJL0fGR6fBL8pMZ4pySVmHNRDd4_GqT4a4Vc1OKzgXnWAeKaFeE9w5Rhwiv69h90G9cUaqsqJRiTgxTiLzXq-gAfXKz3mp2puuwFRUTWVlXq4j9UnRYWb2Ko3133jwTvDgQT6LlMOc5r8THkY5DsQZNizgncUzMwUrtMqn0mVc2kesikwlX05rCNT5I_CaS_AS9_2hE</recordid><startdate>20210823</startdate><enddate>20210823</enddate><creator>Wei, Xin</creator><creator>Meel, Michaël H</creator><creator>Breur, Marjolein</creator><creator>Bugiani, Marianna</creator><creator>Hulleman, Esther</creator><creator>Phoenix, Timothy N</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4771-4003</orcidid></search><sort><creationdate>20210823</creationdate><title>Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas</title><author>Wei, Xin ; Meel, Michaël H ; Breur, Marjolein ; Bugiani, Marianna ; Hulleman, Esther ; Phoenix, Timothy N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c594t-75d275278f65521d255f9f865a9e522353b4079ca53b5f4f17d6b8ef081ea5c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Antibodies</topic><topic>Blood brain barrier</topic><topic>Blood-Brain Barrier - pathology</topic><topic>Brain - blood supply</topic><topic>Brain - pathology</topic><topic>Brain cancer</topic><topic>Brain Neoplasms - pathology</topic><topic>Brain tumors</topic><topic>Child</topic><topic>Diffuse intrinsic pontine glioma</topic><topic>Diffuse midline glioma</topic><topic>Endothelial cells</topic><topic>Glioma</topic><topic>Glioma - pathology</topic><topic>Gliomas</topic><topic>Histology</topic><topic>Humans</topic><topic>Mice</topic><topic>Mice, Inbred NOD</topic><topic>Mice, SCID</topic><topic>Mutation</topic><topic>Neoplasm Grading - methods</topic><topic>Neurovascular Coupling - physiology</topic><topic>Neurovascular unit</topic><topic>Pediatric high-grade glioma</topic><topic>Pediatrics</topic><topic>Plasmids</topic><topic>Tumors</topic><topic>Xenograft Model Antitumor Assays - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wei, Xin</creatorcontrib><creatorcontrib>Meel, Michaël H</creatorcontrib><creatorcontrib>Breur, Marjolein</creatorcontrib><creatorcontrib>Bugiani, Marianna</creatorcontrib><creatorcontrib>Hulleman, Esther</creatorcontrib><creatorcontrib>Phoenix, Timothy N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Acta neuropathologica communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wei, Xin</au><au>Meel, Michaël H</au><au>Breur, Marjolein</au><au>Bugiani, Marianna</au><au>Hulleman, Esther</au><au>Phoenix, Timothy N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas</atitle><jtitle>Acta neuropathologica communications</jtitle><addtitle>Acta Neuropathol Commun</addtitle><date>2021-08-23</date><risdate>2021</risdate><volume>9</volume><issue>1</issue><spage>142</spage><epage>142</epage><pages>142-142</pages><artnum>142</artnum><issn>2051-5960</issn><eissn>2051-5960</eissn><abstract>The blood-brain barrier (BBB) plays important roles in brain tumor pathogenesis and treatment response, yet our understanding of its function and heterogeneity within or across brain tumor types remains poorly characterized. Here we analyze the neurovascular unit (NVU) of pediatric high-grade glioma (pHGG) and diffuse midline glioma (DMG) using patient derived xenografts and natively forming glioma mouse models. We show tumor-associated vascular differences between these glioma subtypes, and parallels between PDX and mouse model systems, with DMG models maintaining a more normal vascular architecture, BBB function and endothelial transcriptional program relative to pHGG models. Unlike prior work in angiogenic brain tumors, we find that expression of secreted Wnt antagonists do not alter the tumor-associated vascular phenotype in DMG tumor models. Together, these findings highlight vascular heterogeneity between pHGG and DMG and differences in their response to alterations in developmental BBB signals that may participate in driving these pathological differences.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>34425907</pmid><doi>10.1186/s40478-021-01243-1</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-4771-4003</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2051-5960 |
ispartof | Acta neuropathologica communications, 2021-08, Vol.9 (1), p.142-142, Article 142 |
issn | 2051-5960 2051-5960 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_577c7abe343a43c39671695146a4f1f4 |
source | Publicly Available Content Database; PubMed Central |
subjects | Animals Antibodies Blood brain barrier Blood-Brain Barrier - pathology Brain - blood supply Brain - pathology Brain cancer Brain Neoplasms - pathology Brain tumors Child Diffuse intrinsic pontine glioma Diffuse midline glioma Endothelial cells Glioma Glioma - pathology Gliomas Histology Humans Mice Mice, Inbred NOD Mice, SCID Mutation Neoplasm Grading - methods Neurovascular Coupling - physiology Neurovascular unit Pediatric high-grade glioma Pediatrics Plasmids Tumors Xenograft Model Antitumor Assays - methods |
title | Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T01%3A41%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defining%20tumor-associated%20vascular%20heterogeneity%20in%20pediatric%20high-grade%20and%20diffuse%20midline%20gliomas&rft.jtitle=Acta%20neuropathologica%20communications&rft.au=Wei,%20Xin&rft.date=2021-08-23&rft.volume=9&rft.issue=1&rft.spage=142&rft.epage=142&rft.pages=142-142&rft.artnum=142&rft.issn=2051-5960&rft.eissn=2051-5960&rft_id=info:doi/10.1186/s40478-021-01243-1&rft_dat=%3Cgale_doaj_%3EA673028865%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c594t-75d275278f65521d255f9f865a9e522353b4079ca53b5f4f17d6b8ef081ea5c43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2574489877&rft_id=info:pmid/34425907&rft_galeid=A673028865&rfr_iscdi=true |